Prospera Test Evaluation in Cardiac Transplant (ProTECT)
Running, not enrolling
Conditions studied: Heart Transplant Rejection
In brief
The ProTECT registry is an observational longitudinal, multi-center study observing patients undergoing heart transplant for whom Prospera testing is part of routine clinical care, who are enrolled within 60 days of heart transplantation.
Key facts
- Study ID
- NCT05205551
- Run by
- Natera, Inc.
- People needed
- 411
- Starts
- 2021-10-01
- Expected to finish
- 2027-06-30
- Last updated by the study team
- 2025-05-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Natera — San Carlos, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.